India reserves right to act on patents after Novartis case

GENEVA (Reuters) – Commerce and Industry Minister Anand Sharma said India would revoke drug patents if outbreaks of serious diseases or pandemics made it necessary, defending a Supreme Court ruling against Swiss drug firm Novartis.


read the full story about India reserves right to act on patents after Novartis case

Be the first to comment

Leave a Reply

Your email address will not be published.


*